Loading
Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.
Latest quote
$17.69
+$0.26 · +1.49%
After-hours
$17.69
$0.00 · 0.00%
Oct 9, 5:26 PM ET
Regular session · ET · Market data may be delayed.
Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.
Day range
Current $17.69
52-week range
Current $17.69
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
47
Fair Value
Sentiment
66
Bullish
Risk
59
Elevated Risk
Momentum
50
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.
Day range
Current $17.69
52-week range
Current $17.69
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.25B USD | 2.11B USD | 1.71B USD | 1.56B USD | 1.43B USD |
| Cost of goods sold | 902.79M USD | 926.87M USD | 716.42M USD | 693.72M USD | 648.51M USD |
| Gross profit | 1.35B USD | 1.18B USD | 990.78M USD | 869.38M USD | 777.68M USD |
| Research and development | 120.33M USD | 91.3M USD | 75.33M USD | 60.83M USD | 49.09M USD |
| Selling, general, and administrative | 1.07B USD | 939.36M USD | 830.31M USD | 772.91M USD | 665.78M USD |
| Operating expenses | 1.36B USD | 1.96B USD | 1.06B USD | 940.56M USD | 840.47M USD |
| Interest income | — | — | — | 200K USD | — |
| Interest expense | 34.82M USD | 57.1M USD | 19.75M USD | 24.95M USD | 29.11M USD |
| Depreciation and amortization | 294.38M USD | 284.8M USD | 217.11M USD | 219.71M USD | 262.92M USD |
| Operating income | −18.87M USD | −775.72M USD | −65.71M USD | −71.18M USD | −62.8M USD |
| Net income | −1.18B USD | −825.49M USD | −33.26M USD | −13.29M USD | 71.66M USD |
Company facts updated Oct 9, 2026.
Third-party consensus; not a GoAI recommendation.
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Apr 5, 2022 | 1:3 | — | — |
Effective Apr 5, 2022
1:3
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI42.77M0.00%2.3T USD0.03%$381.94+0.63%
Avantis U.S. Small Cap Value ETFAVUV39.82M0.13%30.82B USD0.25%$119.64-0.41%
Vanguard Morningstar Small-Cap ETFVB30.92M0.02%185.3B USD0.03%$289.48+0.64%
iShares Russell 2000 ETFIWM26.47M0.03%77.7B USD0.19%$278.94+0.49%
Vanguard Morningstar Small-Cap Value ETFVBR19.65M0.03%68.2B USD0.05%$234.43+0.22%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV16.54M0.06%26.91B USD0.33%$37.95-0.39%
Vanguard Extended Market ETFVXF16.44M0.02%95.4B USD0.05%$235+0.80%
Dimensional - US Targeted Value ETFDFAT9.48M0.03%30.26B USD0.33%$67.27-0.43%Vanguard Morningstar Total Stock Market ETFVTIAvantis U.S. Small Cap Value ETFAVUVVanguard Morningstar Small-Cap ETFVBiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap Value ETFVBRU.S. Small Cap Value Portfolio ETF Class SharesDFSVVanguard Extended Market ETFVXFDimensional - US Targeted Value ETFDFATAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
